Neuropix

Neuropix, with the slogan "Enhancing Lives with Bioelectronics," is revolutionizing healthcare through wearable neurotechnology. The company's innovative approach integrates bioelectrical treatments with software technology, aiming to improve the overall quality of life and reshape current healthcare practices. Utilizing neuromodulation, Neuropix offers a safe, effective, non-pharmacological treatment for challenging neurological disorders. Drawing on over 10 years of clinical research, the company has developed specially engineered bioelectrical paradigms in collaboration with leading scientists. These paradigms are designed to communicate with the human nervous system through wearable applications, offering relief from diseases and transforming disease management. Founded in 2019, Neuropix operates within the Health Care and Manufacturing industries, with its headquarters based in Hong Kong S.a.r. The latest investment of HKD1.30M, in the form of Non Equity Assistance, was secured on 01 October 2023, with the backing of Start-up Express. The company's groundbreaking approach and recent financial support position it as a promising player in the evolving landscape of healthcare technology.